glp-1 receptor agonists side effects and Research to Treat Overeating and Substance Use Disorders GLP-1 Drugs and Their Effects

Drugs in this class In the UK, the following incretin mimetics are available for type 2 diabetic patients (trade name first, generic name in brackets): Bydureon (Exenatide) taken once weekly Byetta (Exenatide) taken twice daily Lyxumia (lixisenatide) taken once daily Trulicity (Dulaglutide) taken once weekly Victoza (Liraglutide) taken once daily Ozempic (Semaglutide) take once a week Byetta and Bydureon are the same medical drug

Fortis Hospital, Mohali has partnered with HealthifyMe to bridge digital coaching with professional obesity care, creating a pathway from app-based habit formation to clinical intervention when needed

doi:10.1056/NEJMoa1501352

Large-scale pharmaceutical and research investment in these areas has led to the development of a number of effective treatment options, with the glucagon-like peptide-1 (GLP-1) agonists being the most well-known.3 This is partly due to their effectiveness, but many have been influenced by celebrities and online personalities championing these medications for weight loss